{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:39:19Z","timestamp":1774431559458,"version":"3.50.1"},"reference-count":40,"publisher":"Pleiades Publishing Ltd","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Evol Biochem Phys"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1134\/s002209302202020x","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T12:04:03Z","timestamp":1652702643000},"page":"523-534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Horizons of Heparin Therapy in COVID-19 and Pandemic-Related Diseases"],"prefix":"10.1134","volume":"58","author":[{"given":"M. V.","family":"Kondashevskaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"issue":"9","key":"8220_CR1","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s10067-020-05275-1","volume":"39","author":"S Ahmed","year":"2020","unstructured":"Ahmed S, Zimba O, Gasparyan AY (2020) Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow\u2019s triad. Clin Rheumatol 39(9): 2529\u20132543. https:\/\/doi.org\/10.1007\/s10067-020-05275-1","journal-title":"Clin Rheumatol"},{"issue":"10223","key":"8220_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"H Huang","year":"2020","unstructured":"Huang H, Zhang M, Chen C, Zhang H, Wei Y, Tian J, Shang J, Deng Y, Du A, Dai H (2020) Clinical features of patients infected with 2019 novel corona-virus in Wuhan, China. Lancet 395(10223): 497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"issue":"1","key":"8220_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13063-021-05076-0","volume":"22","author":"M Sholzberg","year":"2021","unstructured":"Sholzberg M, Tang GH, Negri E, Rahhal H, Kreuziger LB, Pompilio CE, James P, Fralick M, AlHamzah M, Alomran F, Tseng E, Lim G, Lillicrap D, Carrier M, \u00c1inle FN, Beckett A, da Costa BR, Thorpe K, Middeldorp S, Lee A, Cushman M, J\u00fcni P (2021) Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG\u2014RAPID Trial): A structured summary of a study protocol for a randomised controlled trial. Trials 22(1): 202. https:\/\/doi.org\/10.1186\/s13063-021-05076-0","journal-title":"Trials"},{"key":"8220_CR4","unstructured":"World Health Organization (2020) Clinical management of COVID-19. https:\/\/www.who.int\/publications\/i\/item\/clinical-management-ofCOVID-19"},{"issue":"1","key":"8220_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/01.cir.19.1.75","volume":"19","author":"J McLEAN","year":"1959","unstructured":"McLEAN J (1959) The discovery of heparin. Circulation 19(1):75\u201378. https:\/\/doi.org\/10.1161\/01.cir.19.1.75","journal-title":"Circulation"},{"issue":"5","key":"8220_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.hoc.2016.06.002","volume":"30","author":"RI Handin","year":"2016","unstructured":"Handin RI (2016) The history of antithrombotic therapy: the discovery of heparin, the vitamin K antagonists, and the utility of aspirin. Hematol Oncol Clin North Am 30(5): 987\u2013993. https:\/\/doi.org\/10.1016\/j.hoc.2016.06.002","journal-title":"Hematol Oncol Clin North Am"},{"key":"8220_CR7","first-page":"64","volume-title":"The ecosystem of mast cells is a key multifunctional component of the body of animals and humans. Review","author":"MV Kondashevskaya","year":"2019","unstructured":"Kondashevskaya MV (2019) The ecosystem of mast cells is a key multifunctional component of the body of animals and humans. Review. Group MDV of Russia, M. ISBN 978-5906748-08-9 K 64 (In Russ)."},{"issue":"2","key":"8220_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.15690\/vramn1284","volume":"76","author":"MV Kondashevskaya","year":"2021","unstructured":"Kondashevskaya MV (2021) Mast cell heparin\u2014new information on the old component. Review. Bulletin of the Russian Academy of Medical Sciences 76 (2): 149\u2013158 https:\/\/doi.org\/10.15690\/vramn1284","journal-title":"Bulletin of the Russian Academy of Medical Sciences"},{"issue":"2","key":"8220_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.15690\/vramn1284","volume":"76","author":"MV Kondashevskaya","year":"2010","unstructured":"Kondashevskaya MV (2010) Modern ideas about the role of heparin in hemostasis and regulation of enzymatic and hormonal activity. Review. Bulletin of the Russian Academy of Medical Sciences 76 (2): 149\u2013158 (In Russ).","journal-title":"Bulletin of the Russian Academy of Medical Sciences"},{"issue":"5","key":"8220_CR10","first-page":"731","volume":"110","author":"BA Kudrjashov","year":"1983","unstructured":"Kudrjashov BA, Pastorova VE, Lyapina LA (1983) Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo. Folia Haematol Int Mag Klin Morphol Blutforsch 110(5): 731\u2013742.","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"key":"8220_CR11","doi-asserted-by":"publisher","unstructured":"Al\u00e1ez-Vers\u00f3n CR, Lantero E, Fern\u00e0ndez-Busquets X (2017) Heparin: new life for an old drug. Nanomedicine (Lond) 12(14): 1727\u20131744. https:\/\/doi.org\/10.2217\/nnm-20170127","DOI":"10.2217\/nnm-20170127"},{"issue":"43","key":"8220_CR12","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"SR Tipnis","year":"2000","unstructured":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensinconverting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275(43): 33238\u201333243. https:\/\/doi.org\/10.1074\/jbc.M002615200","journal-title":"J Biol Chem"},{"issue":"4","key":"8220_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.36233\/0372-9311-2020-97-4-6","volume":"97","author":"PO Shatunova","year":"2020","unstructured":"Shatunova PO, Bykov AS, Svitich OA, Zverev VV (2020) Angiotensin-converting enzyme 2. Approaches to pathogenetic therapy of COVID-19. Microbiol, Epidemiol and Immunobiol 97(4): 339\u2013349 https:\/\/doi.org\/10.36233\/0372-9311-2020-97-4-6","journal-title":"Microbiol, Epidemiol and Immunobiol"},{"key":"8220_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M\u00fcller MA, Drosten C, P\u00f6hlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181: 271\u2013280. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"issue":"142","key":"8220_CR15","doi-asserted-by":"publisher","first-page":"109743","DOI":"10.1016\/j.mehy.2020.109743","volume":"20","author":"FB Belen-Apak","year":"2020","unstructured":"Belen-Apak FB, Sarialioglu F (2020) The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases? Med Hypotheses 20(142): 109743. https:\/\/doi.org\/10.1016\/j.mehy.2020.109743","journal-title":"Med Hypotheses"},{"key":"8220_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.antiviral.2017.04.017","volume":"143","author":"CW Tan","year":"2017","unstructured":"Tan CW, Sam IC, Chong WL, Lee VS, Chan YF (2017) Polysulfonatesuramin inhibits Zika virus infection. Antiviral Res 143: 186\u2013194. https:\/\/doi.org\/10.1016\/j.antiviral.2017.04.017","journal-title":"Antiviral Res"},{"issue":"6","key":"8220_CR17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/cells10061419","volume":"10","author":"LJ Partridge","year":"2021","unstructured":"Partridge LJ, Urwin L, Nicklin MJH, James DC, Green LR, Monk PN (2021) ACE2-independent interaction of SARS-CoV-2 spike protein with human epithelial cells is inhibited by unfractionated heparin. Cells 10(6): 1419. https:\/\/doi.org\/10.3390\/cells10061419","journal-title":"Cells"},{"key":"8220_CR18","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nm.2843","volume":"18","author":"EP Schmidt","year":"2012","unstructured":"Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L, Zemans RL, Bowman JC, Koyanagi DE, Yunt ZX, Smith LP, Cheng SS, Overdier KH, Thompson KR, Geraci MW, Douglas IS, Pearse DB, Tuder RM (2012) The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 18: 1217\u20131223. https:\/\/doi.org\/10.1038\/nm.2843","journal-title":"Nat Med"},{"issue":"2","key":"8220_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383(2): 120\u2013128. https:\/\/doi.org\/10.1056\/NEJMoa2015432","journal-title":"N Engl J Med"},{"issue":"14","key":"8220_CR20","doi-asserted-by":"publisher","first-page":"e140971","DOI":"10.1172\/jci.insight.140971","volume":"5","author":"Y Kanthi","year":"2020","unstructured":"Kanthi Y, Knight JS, Zuo Y, Pinsky DJ (2020) New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm. JCI Insight 5(14): e140971. https:\/\/doi.org\/10.1172\/jci.insight.140971","journal-title":"JCI Insight"},{"issue":"8","key":"8220_CR21","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1177\/1076029616673733","volume":"23","author":"JF Vojacek","year":"2017","unstructured":"Vojacek JF (2017) Should we replace the terms intrinsic and extrinsic coagulation pathways with tissue factor pathway? Clin Appl Thromb Hemost 23(8): 922\u2013927. https:\/\/doi.org\/10.1177\/1076029616673733","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"8220_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10517-007-0094-y","volume":"143","author":"TYu Obergan","year":"2007","unstructured":"Obergan TYu, Lyapina LA, Pastorova VE (2007) Antithrombotic activity of heparin-ATP complex. Bull Exp Biol Med 143(3): 299\u2013301. https:\/\/doi.org\/10.1007\/s10517-007-0094-y","journal-title":"Bull Exp Biol Med"},{"issue":"23","key":"8220_CR23","doi-asserted-by":"publisher","first-page":"11075","DOI":"10.1016\/S0021-9258(18)37923-7","volume":"263","author":"TK Ghosh","year":"1988","unstructured":"Ghosh TK, Eis PS, Mullaney JM, Ebert CL, Gill DL (1988) Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. J Biol Chem 263(23):11075\u201311079.","journal-title":"J Biol Chem"},{"issue":"9","key":"8220_CR24","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1016\/S0021-9258(17)35637-5","volume":"261","author":"CH Pletcher","year":"1986","unstructured":"Pletcher CH, Cunningham MT, Nelsestuen GL (1986) Molecular weight analysis of antithrombin III-heparin and antithrombin III-thrombin-heparin complexes. J Biol Chem 261(9): 4143\u20134147.","journal-title":"J Biol Chem"},{"issue":"39","key":"8220_CR25","first-page":"1352","volume":"119","author":"D Meyer","year":"1989","unstructured":"Meyer D, Tsakiris DA, Marbet GA (1989) Thrombin-antithrombin III complexes as a measure of effective heparin treatment? Schweiz Med Wochenschr 119(39): 1352\u20131354.","journal-title":"Schweiz Med Wochenschr"},{"issue":"3","key":"8220_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0049-3848(78)90126-3","volume":"13","author":"BA Kudrjashov","year":"1978","unstructured":"Kudrjashov BA, Liapina LA, Uljanov AM (1978) Complex fibrinogen-heparin (FH) and fibrinogen degradation products (FDP) in blood of rats after intravenous injection of thrombin. Thrombosis Research 13(3): 397\u2013407.","journal-title":"Thrombosis Research"},{"issue":"3","key":"8220_CR27","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","volume":"100","author":"H-L Ji","year":"2020","unstructured":"Ji H-L, Zhao R, Matalon S, Matthay MA (2020) Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility. Physiol Rev 100(3): 1065\u20131075. https:\/\/doi.org\/10.1152\/physrev.00013.2020","journal-title":"Physiol Rev"},{"issue":"7","key":"8220_CR28","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/jth.14872","volume":"18","author":"CS Whyte","year":"2020","unstructured":"Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ (2020) Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost 18(7): 1548\u20131555. https:\/\/doi.org\/10.1111\/jth.14872","journal-title":"J Thromb Haemost"},{"issue":"3","key":"8220_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/rth2.12109","volume":"2","author":"S Antoniak","year":"2018","unstructured":"Antoniak S (2018) The coagulation system in host defense. Res Pract Thromb Haemost 2(3): 549\u2013557. https:\/\/doi.org\/10.1002\/rth2.12109","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"8220_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s12035-020-02093-z","volume":"58","author":"WY Ong","year":"2021","unstructured":"Ong WY, Go ML, Wang DY, Cheah IK, Halliwell B (2021) Effects of antimalarial drugs on neuroinflammation-potential use for treatment of COVID-19-related neurologic complications. Mol Neurobiol 58(1): 106\u2013117. https:\/\/doi.org\/10.1007\/s12035-020-02093-z","journal-title":"Mol Neurobiol"},{"issue":"1","key":"8220_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.31088\/CEM2021.10.1.11-20","volume":"10","author":"LM Somova","year":"2021","unstructured":"Somova LM, Kotsyurbiy EA, Drobot EI, Lyapun IN, Shchelkanov MYu (2021) Clinical and morphological manifestations of immune system dysfunction in new coronavirus infection (COVID-19). Clin Exp Morphology 10(1):11\u201320 https:\/\/doi.org\/10.31088\/CEM2021.10.1.11-20","journal-title":"Clin Exp Morphology"},{"issue":"5","key":"8220_CR32","doi-asserted-by":"publisher","first-page":"e0233644","DOI":"10.1371\/journal.pone.0233644","volume":"15","author":"J Hogwood","year":"2020","unstructured":"Hogwood J, Pitchford S, Mulloy B, Page C, Gray E (2020) Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole blood. PLoS One 15(5):e0233644. https:\/\/doi.org\/10.1371\/journal.pone.0233644","journal-title":"PLoS One"},{"key":"8220_CR33","doi-asserted-by":"publisher","first-page":"8844280","DOI":"10.1155\/2020\/8844280","volume":"2020","author":"IG Fernandes","year":"2020","unstructured":"Fernandes IG, de Brito CA, Dos Reis VMS, Sato MN, Pereira NZ (2020) SARS-CoV-2 and other respiratory viruses: what does oxidative stress have to do with it? Oxid Med Cell Longev 2020:8844280. https:\/\/doi.org\/10.1155\/2020\/8844280","journal-title":"Oxid Med Cell Longev"},{"issue":"4e","key":"8220_CR34","doi-asserted-by":"publisher","first-page":"01723","DOI":"10.1128\/mBio.01723-20","volume":"11","author":"JC Onishi","year":"2020","unstructured":"Onishi JC, H\u00e4ggblom MM, Shapses SA (2020) Can dietary fatty acids affect the COVID-19 infection outcome in vulnerable populations? mBio 11(4e): 01723\u201320. https:\/\/doi.org\/10.1128\/mBio.01723-20","journal-title":"mBio"},{"issue":"4","key":"8220_CR35","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.21873\/invivo.12528","volume":"35","author":"SF Assimakopoulos","year":"2021","unstructured":"Assimakopoulos SF, Mastronikolis S, De Lastic AL, Aretha D, Papageorgiou D, Chalkidi T, Oikonomou I, Triantos C, Mouzaki A, Marangos M (2021) Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia. In Vivo 35(4): 2483\u20132488. https:\/\/doi.org\/10.21873\/invivo.12528","journal-title":"In Vivo"},{"issue":"9","key":"8220_CR36","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.3390\/ijms21093097","volume":"21","author":"LF Li","year":"2020","unstructured":"Li LF, Liu YY, Lin SW, Chang CH, Chen NH, Hung CY, Lee CS (2020) Low-Molecular-Weight Heparin Reduces Ventilation-Induced Lung Injury through Hypoxia Inducible Factor-1\u03b1 in a Murine Endotoxemia Model. Int J Mol Sci 21(9):3097. https:\/\/doi.org\/10.3390\/ijms21093097","journal-title":"Int J Mol Sci"},{"key":"8220_CR37","doi-asserted-by":"publisher","unstructured":"Dom\u00ednguez-Salas S, G\u00f3mez-Salgado J, Andr\u00e9s-Villas M, D\u00edaz-Milan\u00e9s D, Romero-Mart\u00edn M, Ruiz-Frutos C (2020) Psycho-Emotional Approach to the Psychological Distress Related to the COVID-19 Pandemic in Spain: A Cross-Sectional Observational Study. Healthcare (Basel) 8(3): E190. https:\/\/doi.org\/10.3390\/healthcare8030190","DOI":"10.3390\/healthcare8030190"},{"issue":"10","key":"8220_CR38","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s10517-018-4018-9","volume":"164","author":"MV Kondashevskaya","year":"2018","unstructured":"Kondashevskaya MV (2018) Experimental evaluation of the effects of low-dose heparin on the behavior and morphofunctional status of the liver in Wistar rats with posttraumatic stress disorders. Bull Exp Biol Med 164(10): 490\u2013494. https:\/\/doi.org\/10.1007\/s10517-018-4018-9","journal-title":"Bull Exp Biol Med"},{"key":"8220_CR39","unstructured":"Kudriashov BA, Shapiro FB, Lomovskaia EG, Liapina LA (1975) The role of adrenaline and ACTH in the process of complex heparin compound formation in the blood during imobilization stress. Probl Endokrinol (Mosk) 21(5):54\u201359. (In Russ)."},{"key":"8220_CR40","first-page":"345","volume":"3","author":"LA Lyapina","year":"2000","unstructured":"Lyapina LA, Kondashevskaya MV, Ziadetdinova GA, Uspenskaya MS (2000) Comparative study of anticoagulants from various extracts of Paeonia anomala. Izv Akad Nauk Ser Biol 3:345\u2013349. (In Russ).","journal-title":"Izv Akad Nauk Ser Biol"}],"container-title":["Journal of Evolutionary Biochemistry and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S002209302202020X.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S002209302202020X","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S002209302202020X.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:04:55Z","timestamp":1774422295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S002209302202020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["8220"],"URL":"https:\/\/doi.org\/10.1134\/s002209302202020x","relation":{},"ISSN":["0022-0930","1608-3202"],"issn-type":[{"value":"0022-0930","type":"print"},{"value":"1608-3202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"27 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have neither evident nor potential\nconflict of interest related to the publication of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}